Mead Johnson Nutrition misses by $0.01, reports revs in-line; guides FY14 EPS in-line
Reports Q2 (Jun) earnings of $0.88 per share, $0.01 worse than the Capital IQ Consensus Estimate of $0.89; revenues rose 5.3% year/year to $1.11 bln vs the $1.11 bln consensus.
- The Asia segment reported sales of $575.6 million for the second quarter of 2014, up eight percent from $534.2 million in the prior-year quarter.
- The Latin America segment reported sales of $224.4 million for the second quarter of 2014, up one percent from $223.2 million in the same period of the prior year.
- The North America/Europe segment reported sales of $311.1 million for the second quarter of 2014, up four percent from $297.9 million in the second quarter of 2013.